A broad spectrum of concomitant disorders may complicate heart failure adding further morbidity and mortality risk. Comorbidities may be subdivided into cardiovascular and noncardiovascular. The first group includes hypertension, coronary artery disease, peripheral artery disease, cerebrovascular disease, arrhythmias and valvular heart disease. Noncardiovascular comorbidities include respiratory, endocrine, metabolic, nutritional, renal, hematopoietic, neurological as well as musculoskeletal conditions. In recent years, advances in the treatment of heart failure have not been attended by important changes in management of its comorbidities. They now seem to be major causes of the poor prognosis of heart failure patients. In this review we provide an updated summary of the epidemiological, pathophysiological and clinical characteristics of comorbidities as well as their potential impact for heart failure treatment.

Heart Failure Study Group of the Italian Society of Cardiology. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure / M., Metra; V., Zacà; G., Parati; P., Agostoni; M., Bonadies; M., Ciccone; DEI CAS, Alessandra; M., Iacoviello; R., Lagioia; C., Lombardi; R., Maio; D., Magrì; G., Musca; M., Padeletti; F., Perticone; N., Pezzali; M., Piepoli; A., Sciacqua; L., Zanolla; S., Nodari; Pp, Filardi; L., DEI CAS. - In: JOURNAL OF CARDIOVASCULAR MEDICINE. - ISSN 1558-2027. - 12(2):(2011), pp. 76-84. [10.2459/JCM.0b013e32834058d1]

Heart Failure Study Group of the Italian Society of Cardiology. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure.

DEI CAS, Alessandra;
2011-01-01

Abstract

A broad spectrum of concomitant disorders may complicate heart failure adding further morbidity and mortality risk. Comorbidities may be subdivided into cardiovascular and noncardiovascular. The first group includes hypertension, coronary artery disease, peripheral artery disease, cerebrovascular disease, arrhythmias and valvular heart disease. Noncardiovascular comorbidities include respiratory, endocrine, metabolic, nutritional, renal, hematopoietic, neurological as well as musculoskeletal conditions. In recent years, advances in the treatment of heart failure have not been attended by important changes in management of its comorbidities. They now seem to be major causes of the poor prognosis of heart failure patients. In this review we provide an updated summary of the epidemiological, pathophysiological and clinical characteristics of comorbidities as well as their potential impact for heart failure treatment.
2011
Heart Failure Study Group of the Italian Society of Cardiology. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure / M., Metra; V., Zacà; G., Parati; P., Agostoni; M., Bonadies; M., Ciccone; DEI CAS, Alessandra; M., Iacoviello; R., Lagioia; C., Lombardi; R., Maio; D., Magrì; G., Musca; M., Padeletti; F., Perticone; N., Pezzali; M., Piepoli; A., Sciacqua; L., Zanolla; S., Nodari; Pp, Filardi; L., DEI CAS. - In: JOURNAL OF CARDIOVASCULAR MEDICINE. - ISSN 1558-2027. - 12(2):(2011), pp. 76-84. [10.2459/JCM.0b013e32834058d1]
File in questo prodotto:
File Dimensione Formato  
01244665-201102000-00002.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 300.15 kB
Formato Adobe PDF
300.15 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2431436
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 60
  • ???jsp.display-item.citation.isi??? 53
social impact